Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020115750 - CANNABIS-BASED COMPOSITIONS FOR THE TREATMENT OF MIGRAINE AND HEADACHE

Publication Number WO/2020/115750
Publication Date 11.06.2020
International Application No. PCT/IL2019/051332
International Filing Date 05.12.2019
IPC
A61K 31/352 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61P 25/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
06Antimigraine agents
Applicants
  • TO PHARMACEUTICALS LLC [US]/[US]
  • BAR-LEV SCHLEIDER, Lihi [IL]/[IL] (MW)
Inventors
  • BAR-LEV SCHLEIDER, Lihi
  • TAUBENFELD, Sid
Agents
  • BENSHAFRUT, Ronnie
Priority Data
62/776,08406.12.2018US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) CANNABIS-BASED COMPOSITIONS FOR THE TREATMENT OF MIGRAINE AND HEADACHE
(FR) COMPOSITIONS À BASE DE CANNABIS POUR LE TRAITEMENT DE LA MIGRAINE ET DES CÉPHALÉES
Abstract
(EN)
The invention relates to therapeutic products and methods applicable to the treatment of headache and migraine in particular. To that end, the products and methods of the invention apply certain type of cannabis-based compositions with a high content THC and a low content of all other cannabinoids, provided under specific dose regimens and modes of administration.
(FR)
L'invention concerne des produits thérapeutiques et des procédés applicables au traitement de la céphalée et de la migraine en particulier. À cet effet, les produits et les procédés de l'invention appliquent un certain type de compositions à base de cannabis à forte teneur en THC et à faible teneur en tous les autres cannabinoïdes, fournies dans des schémas posologiques et des modes d'administration déterminés.
Latest bibliographic data on file with the International Bureau